In the context of continuing global crises and diminishing donor funding, grassroots organisations and advocacy networks are facing difficult circumstances in maintaining services and advocating for ...

Today, Pride is still an uprising. Keeping HIV awareness and prevention at the heart of Pride Month deepens its mission and ...

Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...

In 2012, the FDA approved Truvada, also made by Gilead Sciences, making it the first PrEP medication for HIV prevention in uninfected adults in the United States – but “even though PrEP has ...

It is already approved in multiple countries for the treatment of multi-drug-resistant HIV and is now entering the prevention space with unprecedented speed. That speed is critical.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

2:38 Risk of 2,000 new HIV infections daily after US aid freeze, UN AIDS agency estimates The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an ...